Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Zeitlin

Showing results (151-160 of 161) with videos related to

Pageof 17
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 18, 2017
Pharmacokinetics and safety of cavosonstat (N91115) in healthy and cystic fibrosis adults homozygous for F508DEL-CFTRScott H Donaldson, George M Solomon, Pamela L Zeitlin, et al.
Human Gene Therapy|July 30, 2003
Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical studyTerence R Flotte, Pamela L Zeitlin, Thomas C Reynolds, et al.
American Journal of Respiratory and Critical Care Medicine|September 13, 2003
Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosisClaudia L Ordoñez, Noreen R Henig, Nicole Mayer-Hamblett, et al.
Pediatric Pulmonology|April 20, 2004
Standardized procedure for measurement of nasal potential difference: an outcome measure in multicenter cystic fibrosis clinical trialsThomas A Standaert, Louis Boitano, Julia Emerson, et al.
JCI Insight|December 21, 2018
Effect of ivacaftor on mucociliary clearance and clinical outcomes in cystic fibrosis patients with G551D-CFTRScott H Donaldson, Beth L Laube, Timothy E Corcoran, et al.
American Journal of Respiratory and Critical Care Medicine|December 14, 2002
Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosisRonald L Gibson, Julia Emerson, Sharon McNamara, et al.
Human Gene Therapy|August 10, 2007
Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trialRichard B Moss, Carlos Milla, John Colombo, et al.
Molecular & Cellular Proteomics : MCP|July 11, 2006
De novo biosynthetic profiling of high abundance proteins in cystic fibrosis lung epithelial cellsHarvey B Pollard, Ofer Eidelman, Catherine Jozwik, et al.
JCI Insight|May 24, 2022
IL-13-programmed airway tuft cells produce PGE2, which promotes CFTR-dependent mucociliary functionMaya E Kotas, Camille M Moore, Jose G Gurrola, et al.
The European Respiratory Journal|November 18, 2017
Airway microbiota across age and disease spectrum in cystic fibrosisEdith T Zemanick, Brandie D Wagner, Charles E Robertson, et al.
Pageof 17

Showing results (151-160 of 161) with videos related to

Sort By:
Pageof 17
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 18, 2017
Pharmacokinetics and safety of cavosonstat (N91115) in healthy and cystic fibrosis adults homozygous for F508DEL-CFTRScott H Donaldson, George M Solomon, Pamela L Zeitlin, et al.
Human Gene Therapy|July 30, 2003
Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical studyTerence R Flotte, Pamela L Zeitlin, Thomas C Reynolds, et al.
American Journal of Respiratory and Critical Care Medicine|September 13, 2003
Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosisClaudia L Ordoñez, Noreen R Henig, Nicole Mayer-Hamblett, et al.
Pediatric Pulmonology|April 20, 2004
Standardized procedure for measurement of nasal potential difference: an outcome measure in multicenter cystic fibrosis clinical trialsThomas A Standaert, Louis Boitano, Julia Emerson, et al.
JCI Insight|December 21, 2018
Effect of ivacaftor on mucociliary clearance and clinical outcomes in cystic fibrosis patients with G551D-CFTRScott H Donaldson, Beth L Laube, Timothy E Corcoran, et al.
American Journal of Respiratory and Critical Care Medicine|December 14, 2002
Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosisRonald L Gibson, Julia Emerson, Sharon McNamara, et al.
Human Gene Therapy|August 10, 2007
Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trialRichard B Moss, Carlos Milla, John Colombo, et al.
Molecular & Cellular Proteomics : MCP|July 11, 2006
De novo biosynthetic profiling of high abundance proteins in cystic fibrosis lung epithelial cellsHarvey B Pollard, Ofer Eidelman, Catherine Jozwik, et al.
JCI Insight|May 24, 2022
IL-13-programmed airway tuft cells produce PGE2, which promotes CFTR-dependent mucociliary functionMaya E Kotas, Camille M Moore, Jose G Gurrola, et al.
The European Respiratory Journal|November 18, 2017
Airway microbiota across age and disease spectrum in cystic fibrosisEdith T Zemanick, Brandie D Wagner, Charles E Robertson, et al.
Pageof 17